Cargando…
The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
BACKGROUND: High-density lipoproteins (HDL) and their main apolipoprotein, apoA-I, exhibit anti-inflammatory properties. The development of peptides that mimic HDL apolipoproteins offers a promising strategy to reduce inflammatory disease. This study aimed to compare the anti-inflammatory effects of...
Autores principales: | Di Bartolo, Belinda A, Vanags, Laura Z, Tan, Joanne TM, Bao, Shisan, Rye, Kerry-Anne, Barter, Philip J, Bursill, Christina A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276454/ https://www.ncbi.nlm.nih.gov/pubmed/22128776 http://dx.doi.org/10.1186/1476-511X-10-224 |
Ejemplares similares
-
Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis
por: Morton, Jamie, et al.
Publicado: (2018) -
Apolipoprotein A-I Reduces In-Stent Restenosis and Platelet Activation and Alters Neointimal Cellular Phenotype
por: Vanags, Laura Z., et al.
Publicado: (2018) -
Inhibition of Vascular Inflammation by Apolipoprotein A-IV
por: Shearston, Kate, et al.
Publicado: (2022) -
Chemokine binding protein ‘M3’ limits atherosclerosis in apolipoprotein E(-/-) mice
por: Ravindran, Dhanya, et al.
Publicado: (2017) -
Apolipoprotein Mimetic Peptides: A New Approach for the Treatment of Asthma
por: Yao, Xianglan, et al.
Publicado: (2012)